REG - hVIVO PLC - Appointment of Non-Executive Director

hVIVOAnnouncement

Yesterday 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251218:nRSR0189Ma&default-theme=true

RNS Number : 0189M  hVIVO PLC  18 December 2025

 

hVIVO plc

("hVIVO", the "Company" or the "Group")

 

hVIVO strengthens Board with appointment of Richard Cotton as

Non-Executive Director

 

Seasoned life sciences executive with extensive Board and financial expertise

 

hVIVO plc (AIM: HVO), a full-service early phase Contract Research
Organisation (CRO) and the world leader in human challenge clinical trials,
announces the appointment of Richard Cotton as Independent Non-Executive
Director, effective today. Richard will also serve as Chair of the Audit
Committee and as a member of the Remuneration and Nominations Committees.

 

Richard brings extensive Board-level and financial expertise, including
experience serving as Chair, Audit Chair and Senior Independent Director, as
well as holding advisory and senior financial leadership roles across the life
sciences and other sectors.

 

Richard currently serves as Audit Chair and Lead Independent Director at
Nasdaq-listed AI predictive diagnostics company Spectral AI and is Senior
Independent Director and Audit Committee Chair at AIM-listed topical oxygen
wound therapy company AOTI. He is also Financial Adviser at Novumgen, a
privately owned Specialty Pharmaceuticals company, and NED at Sherwood Forest
Hospitals NHS Foundation Trust.

 

His prior executive roles include highly successful tenures as CFO at FTSE150
animal health company Dechra Pharmaceuticals plc, and as CFO at medical device
and drug formulation business Consort Medical plc. A Fellow of the Chartered
Institute of Management Accountants, Mr Cotton holds a BA (Hons) in Business
Studies from Kingston University.

 

Shaun Chilton, Non-Executive Chair of hVIVO plc, said: "We welcome Richard to
the Board of hVIVO. His extensive financial, operational and governance
expertise, combined with his life sciences experience will significantly
enhance the Board's capabilities as we focus on the strategic opportunities
open to the Company and delivering long-term shareholder value."

 

Richard Cotton, Incoming Non-Executive Director of hVIVO plc, said: "I am
excited to be able to contribute my experience and expertise to support
hVIVO's growth. The Company is at an exciting phase with the foundation of a
global leading position in human challenge trials with an increasingly
diversified service offering, a robust pipeline and strong fundamentals. I
look forward to working closely with the Board and leadership team."

 

Additional Information on the Board Appointment

 

The following additional information is provided with regards to the
appointment of Richard John Cotton, aged 64, in accordance with Rule 17 and
Schedule 2(g) of the AIM Rules for Companies:

 

 Current directorships/partnerships:   Former directorships/partnerships (within the last five years):
 Aoti, Inc                             Spectral MD Holdings Ltd
 Sherwood Forest NHS Foundation Trust
 Spectral AI Inc
 Spectral IP Inc
 Spectral MD UK Limited

 

On 24 June 2005, Mr Cotton was appointed as director of Wagon Services Limited
and subsequently resigned as a director on 31 October 2008. Wagon Services
Limited entered administration on 8 December 2008 as a result of a downturn in
trading caused by the global economic conditions at that time and was
subsequently dissolved on 28 February 2010.

 

Mr Cotton was a director of a number of former dormant subsidiaries of McLeod
Russel plc which were liquidated as part of a corporate reorganisation
following its acquisition by SPX Corp. The companies were dissolved by
creditors voluntary liquidation on the dates shown below:

 

 Company Name                                 Date dissolved
 Air Filter Products Ltd                      14 September 2005
 Beck & Frost Ltd                             14 September 2005
 Buchanan's Warehouse Ltd                     09 November 2005
 CRC Air Filters Ltd                          09 November 2005
 Granyte Paints Ltd                           04 November 2005
 Hedgeferry Ltd                               09 November 2005
 Ideas Telecom Ltd                            09 November 2005
 Hole Holdings Ltd                            30 December 2007
 Irwell Leasing Ltd                           13 September 2005
 Jeffes Engineering Ltd                       13 September 2005
 Joseph Mason Paints Ltd                      09 November 2005
 Joseph Mason Paints (Scotland) Ltd           10 September 2005
 Kennedy Industrial Textiles (1990) Ltd       10 September 2005
 Kennedy Smale PLC                            08 November 2005
 Perfection Products Ltd                      08 November 2005
 R&M Knotting Machinery Ltd                   09 November 2005
 Seasafe Ltd                                  13 September 2005
 Seldon (Air Conditioning) Ltd                15 September 2005
 Warren PS Ltd                                14 November 2005
 Wheway Becker Ltd                            13 September 2005
 Wheway Distribution Ltd                      15 September 2005
 Wheway Network Systems Ltd                   14 September 2005
 Wheway (Old Hill) Ltd                        15 September 2005
 Airflow Construction Ltd                     30 December 2007
 Blackwall Warehousing Ltd                    09 January 2008
 Coroless International Ltd                   09 January 2008
 Filter Supply and Manufacturing Company Ltd  09 January 2008
 Granyte Surface Coating (Southern) Ltd       09 January 2008
 H Sharp & Son Ltd                            30 December 2007
 Joseph Mason Ltd                             09 January 2008
 Joseph Shakespeare & Co Ltd                  30 December 2007
 NESW2 Ltd                                    30 December 2007
 NESW3 Ltd                                    30 December 2007
 NESW6 Ltd                                    30 December 2007
 NESW1 Ltd                                    30 December 2007
 NESW5 Ltd                                    30 December 2007
 Heat, Insulation & Ventilation Co. Ltd       09 January 2008
 Methworth Ltd                                30 December 2007
 WPH Papua New Guinea Plantations Ltd         09 January 2008
 Premium Coatings Ltd                         09 January 2008
 Seldon Refrigeration Ltd                     09 January 2008
 Wheway Corporate Services Ltd                09 January 2008
 Wheway Secretarial Services Ltd              09 January 2008
 Wilson Filters Ltd                           09 January 2008

 

 

Mr Cotton does not hold any shares or options in the Company.

 

There are no further disclosures required under Rule 17 and Schedule 2(g) of
the AIM Rules for Companies.

 

For further information please contact:

 

 hVIVO plc                                                                         +44 (0)20 7756 1300
 Yamin 'Mo' Khan, Chief Executive Officer

 Stephen Pinkerton, Chief Financial Officer

 Cavendish Capital Markets Limited (Nominated Adviser and Joint Broker)                                                    +44 (0)20 7220 0500
 Geoff Nash, Callum Davidson

Trisyia Jamaludin, Harriet Ward

 Nigel Birks - Life Science Specialist Sales

 Louise Talbot - Sales

 Peel Hunt LLP (Joint Broker)                                                                          +44 (0)20 7418 8900
 James Steel, Dr Christopher Golden

 Davy (Joint Broker)                                                                                   +353 (0) 1 679 6363
 Anthony Farrell, Niall Gilchrist

 ICR Healthcare (Financial PR & IR)                                                hVIVO@icrhealthcare.com

 Mary-Jane Elliott / Stephanie Cuthbert / Phillip Marriage/ Louis Ashe-Jepson

 

 

 

Notes to Editors

 

hVIVO plc (https://hvivo.com/) (Ticker: HVO) is full-service Contract Research
Organisation (CRO) and the global leader in human challenge trials. The
company delivers end-to-end clinical development services to a diverse and
expanding client base, including seven of the world's ten largest biopharma
companies.

 

hVIVO specialises in conducting human challenge trials across multiple
infectious and respiratory indications, leveraging its state-of-the-art
quarantine facility in London-the largest of its kind worldwide. The company
also offers comprehensive virology and immunology laboratory services under
the hLAB (https://hlabservices.com/) brand.

 

Through its German subsidiary, CRS (https://crs-earlyphase.com/) , hVIVO
operates a 120-bed capacity across Mannheim and Kiel, providing early-phase
clinical trial services, including first-in-human and proof-of-concept
studies. Its second subsidiary, Venn Life Sciences
(https://www.vennlifesciences.com/) , offers Early Drug Development Consulting
and Biometry services to the biopharma sector.

 

The Group provides fully integrated drug development solutions from
preclinical stages through Phase II trials, alongside patient recruitment via
FluCamp (https://flucamp.com/) . Additionally, its five clinical sites support
outpatient Phase II and III trials, ensuring a seamless and efficient pathway
from discovery to late-stage development.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  BOAZZMMZRNLGKZM



            Copyright 2019 Regulatory News Service, all rights reserved